Sign in
4

Changes in Ownership

Propanc Biopharma, Inc. Filed Acc 0001493152-23-029950

Options or other derivatives

  • Director acquired 15,000,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
ZELINGER JOSEF Director 2023-07-05 Grant or award · Common Stock Purchase Warrant +15,000,000 15,000,000 I
Loading xslF345X05/ownership.xml…